Additionally, in mouse models of xenograft with ovarian cancer cells, COL11A1 has been shown to stimulate IL-6 production via induction of TGF-β3, modulating the interaction between CAFs and tumor cells and amplifying tumor invasiveness and progression [172]. Here, COL11A1 is linked to neoplasm.